E207-1570 Screening compound: N~3~-{3-[sec-butyl(2-furylmethyl)amino]propyl}-1-methyl-5,5-dioxo-4,5-dihydro-1H-5lambda~6~-thiochromeno[4,3-c]pyrazole-3-carboxamide

E207-1570 Screening compound: N~3~-{3-[sec-butyl(2-furylmethyl)amino]propyl}-1-methyl-5,5-dioxo-4,5-dihydro-1H-5lambda~6~-thiochromeno[4,3-c]pyrazole-3-carboxamide
E207-1570 Screening compound: N~3~-{3-[sec-butyl(2-furylmethyl)amino]propyl}-1-methyl-5,5-dioxo-4,5-dihydro-1H-5lambda~6~-thiochromeno[4,3-c]pyrazole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E207-1570
N~3~-{3-[sec-butyl(2-furylmethyl)amino]propyl}-1-methyl-5,5-dioxo-4,5-dihydro-1H-5lambda~6~-thiochromeno[4,3-c]pyrazole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E207-1570

Molecular Formula

C24H30N4O4S (C24 H30 N4 O4 S)

Compound Name

N~3~-{3-[sec-butyl(2-furylmethyl)amino]propyl}-1-methyl-5,5-dioxo-4,5-dihydro-1H-5lambda~6~-thiochromeno[4,3-c]pyrazole-3-carboxamide

IUPAC name

N-{3-[(butan-2-yl)[(furan-2-yl)methyl]amino]propyl}-1-methyl-55-dioxo-1H4H-5lambda6-thiochromeno[43-c]pyrazole-3-carboxamide

SMILES

CCC(C)N(CCCNC(c1nn(C)c(-c2c3cccc2)c1CS3(=O)=O)=O)Cc1ccco1

InChI

InChI=1S/C24H30N4O4S/c1-4-17(2)28(15-18-9-7-14-32-18)13-8-12-25-24(29)22-20-16-33(30,31)21-11-6-5-10-19(21)23(20)27(3)26-22/h5-7,9-11,14,17H,4,8,12-13,15-16H2,1-3H3,(H,25,29)/t17-/m0/s1

InChI Key

BWLSMDYMCIHUHF-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD14846429

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

470.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.504

Distribution Coefficient, logD

1.038

Water Solubility, LogSw

-2.92

Polar Surface Area

78.272

Acid Dissociation Constant (pKa)

13.31

Base Dissociation Constant (pKb)

8.85

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.70

E207-1570 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-infective Library (19449 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E207-1570 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E207-1570?
Check Price and Availability of E207-1570, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E207-1570 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E207-1570
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E207-1570
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E207-1570 available by request